Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose naltrexone in pediatric NDPH
NCT03447782Phase 2Completed
- Sponsor
- Boston Children's Hospital
- Start
- Jul 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in new daily persistent headache (NDPH), sponsored by Boston Children's Hospital. Started Jul 2018; status: completed.
02
Drugs
naltrexone
03
Conditions
new daily persistent headache (NDPH)
Beyond the preview
Go deeper on NCT03447782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03447782.